Kohda et al., 1997 - Google Patents
Controlled release of lidocaine hydrochloride from buccal mucosa-adhesive films with solid dispersionKohda et al., 1997
- Document ID
- 3502352057680170734
- Author
- Kohda Y
- Kobayashi H
- Baba Y
- Yuasa H
- Ozeki T
- Kanaya Y
- Sagara E
- Publication year
- Publication venue
- International Journal of Pharmaceutics
External Links
Snippet
Solid dispersion films were prepared with a highly water-soluble medicine, lidocaine hydrochloride (LDC), water-insoluble ethylcellulose (EC) and water-soluble hydroxypropylcellulose (HPC). The release profiles of LDC from the solid dispersion films of …
- 229960004393 Lidocaine Hydrochloride 0 title abstract description 86
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kohda et al. | Controlled release of lidocaine hydrochloride from buccal mucosa-adhesive films with solid dispersion | |
| Meher et al. | Development and characterization of cellulose–polymethacrylate mucoadhesive film for buccal delivery of carvedilol | |
| Alshehri et al. | Mefenamic acid taste-masked oral disintegrating tablets with enhanced solubility via molecular interaction produced by hot melt extrusion technology | |
| Ghosh et al. | A review on new generation orodispersible tablets and its future prospective | |
| JP2633089B2 (en) | Pharmaceutical formulation for transdermal administration having tulobuterol as active substance and method for producing the same | |
| Asada et al. | Theophylline particle design using chitosan by the spray drying | |
| Khan et al. | Formulation, characterisation and stabilisation of buccal films for paediatric drug delivery of omeprazole | |
| US6153216A (en) | Transdermal estradiol/progestogen agent patch and its production | |
| Li et al. | Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique | |
| JPS62267221A (en) | Novel medicine | |
| JPH0327311A (en) | Dermal medical care system showing highly active material flow and its manufacture | |
| AU746373B2 (en) | Active substance carrier for releasing apomorphine into the buccal cavity | |
| JP2010270133A (en) | Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance | |
| WO2003059390A1 (en) | Oral mucoadhesive film | |
| Okeke et al. | Nicotine stabilization in composite sodium alginate based wafers and films for nicotine replacement therapy | |
| Rao et al. | Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits | |
| TWI715291B (en) | Pharmaceutical composition including parp inhibitor | |
| Inoue et al. | Enhancement of skin permeation of ketotifen by supersaturation generated by amorphous form of the drug | |
| Ikeuchi-Takahashi et al. | Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application | |
| Topaloğlu et al. | Inclusion of ketoprofen with skimmed milk by freeze-drying | |
| Wang et al. | Application of asymmetric TPX membranes to transdermal delivery of nitroglycerin | |
| Rajendran | Effect of niosomes in the transdermal delivery of antidepressant sertraline hydrochloride | |
| JP2001508069A (en) | Acetylsalicylic acid-containing transdermal therapeutic system with enhanced absorbability | |
| Kim et al. | Preparation and evaluation of oral dissolving film containing local anesthetic agent, lidocaine | |
| Reddy et al. | Cellulose orodispersible films of donepezil: Film characterization and drug release |